Wednesday, February 1, 2017

Dem Accusations About Tom Price Stock Trades Unsubstantiated


At Free Beacon by Natalie Johnson  -- 

Congressional Democrats delayed the confirmation of Rep. Tom Price (R., Ga.) to head the Department of Health and Human Services on Tuesday due in large part to unsubstantiated media reports citing conflicts of interest between the former congressman’s health care-related financial holdings and legislative activity.

Democrats are concerned about Price's trading history with dozens of medical companies given his involvement with legislation they say would benefit those businesses directly.

Earlier this month, CNN published financial disclosure records showing that Price purchased between $1,001 and $15,000 worth of shares in Zimmer Biomet, a leading medical device manufacturer, in March 2015. A week later, the report stated, the Georgia congressman introduced legislation that would have delayed a Centers for Medicare and Medicaid Services regulation that industry analysts said could have significant financial implications for the company.


No comments:

Post a Comment